From: JAK2 mutation may predict response and guide first line treatment in rheumatoid arthritis
ACR | Non-mutant JAK2 | Mutant JAK2 | X | P |
---|---|---|---|---|
ACR 20 (38 patients) | 12 (31.6%) | 26 (68.4%) | 7.8 | 0.022 |
ACR 50 (25 patients) | 13 (52%) | 12 (48%) | ||
ACR 70 (22 patients) | 15 (68.2%) | 7 (31.8%) |